WO2000001294A1 - Non-invasive measurement of blood analytes - Google Patents
Non-invasive measurement of blood analytes Download PDFInfo
- Publication number
- WO2000001294A1 WO2000001294A1 PCT/GB1999/002127 GB9902127W WO0001294A1 WO 2000001294 A1 WO2000001294 A1 WO 2000001294A1 GB 9902127 W GB9902127 W GB 9902127W WO 0001294 A1 WO0001294 A1 WO 0001294A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood
- fibres
- patient
- absorption value
- transmitter
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
- B65H23/00—Registering, tensioning, smoothing or guiding webs
- B65H23/04—Registering, tensioning, smoothing or guiding webs longitudinally
- B65H23/18—Registering, tensioning, smoothing or guiding webs longitudinally by controlling or regulating the web-advancing mechanism, e.g. mechanism acting on the running web
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
Definitions
- This invention relates to a novel monitor, particularly a monitor for the non-invasive measurement of glucose in eg diabetics and a method for determining glucose levels.
- Diabetes mellitus (abbreviated to diabetes) is the name for a group of chronic or lifelong diseases that affect the way the body uses food to make energy necessary for life. Primarily, diabetes is a disruption of carbohydrate (sugar and starch) metabolism and also affects fats and proteins. In people who have diabetes the glucose levels vary considerably being as high as 40 mmol/1 and as low as 2 rnmol/1. Blood glucose levels in people without diabetes vary very little, staying between 3 and 7 mmol/1. These levels follow the typical patterns shown in Figure la.
- Diabetic eye disease retinopathy
- Diabetic renal disease nephropathy
- Diabetic neuropathy affects the peripheral nerves causing impaired sensation and leg ulcers, and damage to the autonomic nervous system causes postural hypertension (low blood pressure on standing) and diarrhoea.
- Atherosclerosis is 2-4 times as high in diabetic as non-diabetic people and manifest as an increased frequency of myocardial infarction (heart attacks), cerebrovascular disease (strokes) and the peripheral vascular disease (causing reduced circulation to the limbs and the risk of gangrene and amputation).
- the DCCT has been a major stimulus to physicians around the world to renew efforts to improve control in diabetic patients, and to develop improved methods of obtaining good control and of monitoring these patients.
- hypoglycaemia was three-fold higher in the well-controlled patients than those with ordinary control. This confirms the long-standing appreciation by physicians that hypoglycaemia is extremely frequent in IDDM, and especially so in those that are well controlled. There are many reasons for this including mistiming of insulin injections and food, erratic absorption of insulin, and impaired secretion in some diabetic patients of the so-called counter regulatory hormones such as adrenaline and glucagon that oppose the action of insulin.
- hypoglycaemia eg sweating, nausea, blurred vision, palpitations
- hypoglycaemia eg sweating, nausea, blurred vision, palpitations
- the consequences of hypoglycaemia include impaired cognition and consciousness, and eventually coma.
- SBGM Self blood glucose monitoring
- BGMs use either reflectance photometry or an electrochemical method to measure the glucose concentration.
- Reflectance photometry measures the amount of light reflected from the reagent-impregnated test strip that has reacted with a drop of blood.
- the operator pricks the finger of the patient or earlobe with a sterile lancet or uses anticoagulated whole blood collected in heparin and then places the blood on the test strip.
- the operator must place the blood onto the test strip at the time the monitor begins its timing sequence. This step is critical because under-timing (under-incubation) or over-timing (over-incubation) of the reaction may cause inaccurate measurements.
- the operator wipes or blots the excess blood off the outside of the test strip. The operator then inserts the strip into the monitor for measurement.
- a disposable single-use enzyme electrode test strip is used.
- an enzymatic reaction occurs that results in a current through the strip.
- the current is directly proportional to the concentration of glucose in the specimen.
- glucose values obtained with BGMs may not agree with clinical laboratory results. Routine laboratory measurements of glucose are performed on either serum or plasma venous blood specimens that correspond with glucose concentrations measured on whole blood glucose analysers.
- Whole blood glucose values are lower than those obtained from either serum or plasma.
- glucose is not a static component in human blood, changes in blood glucose concentration following food intake in normal and hyperglycaemic conditions are reasonably predictable.
- the variation in glucose concentration as blood passes from arteries or capillaries to veins has also been documented. Therefore, over time, repeated measurement of blood glucose from the same patient may diverge widely.
- blood obtained simultaneously by finger stick and venipuncture may not have the same glucose concentration. (Venous blood may contain 1 mmol/1 less glucose than capillary blood if the same samples are obtained within 1-2 hours after carbohydrate intake).
- haematocrit of the patient influences glucose values, and whole blood glucose measurements must be corrected for this.
- BGMs cannot automatically correct for the haematocrit of the patient, an error of 5-15% may be introduced.
- a non-invasive measurement device is known from US Patent No 5,553,613.
- US '613 describes a technique which uses the pulsatile component of the light intensity transmitted through the finger, from which to derive the glucose concentration non- invasively. It does this by using the wavelengths 805nm, 925nm, 970nm and the range 1000-1 lOOnm. The measurements were made by transmission, ie light was passed through the finger.
- US '613 specifically relies upon the pulsatile component of the light transmitted through the patient.
- Such a pulsatile technique has clear disadvantages in that the pulsatile component of the light signal, whether transmitted or reflected, is less than 2% of the total signal.
- prior art devices which use only the pulsatile component are much less sensitive and much more vulnerable to patient movement which can cause interference which is in the order of a few hundred times the relevant signal.
- the pulsatile signal identifies arterial blood specifically. Whilst this is advantageous when considering the pulmonary circulation of a patient, it provides no information on the patient's systemic circulation which is important for glucose determination. Further, pulsatile techniques are limited to use on body extremities, eg finger, ear lobe or the ball of the foot in babies or neo-nates.
- the present invention overcomes or mitigates the disadvantages of the prior art by using a plurality of closely associated transmitters and generators which allows an "average" evened out signal to be produced and is capable of utilising the non- pulsatile element of the patient's blood flow.
- a further advantage of the invention is that it allows the measurement of oxygen saturation (SO 2 ).
- the invention permits the measurement of haemoglobin index (Hbl) and/or temperature.
- a device for the non-invasive measurement of one or more analytes in blood in a patient's body part which comprises a light transmitter comprising a plurality of transmitting fibres positioned to transmit light to the body part and a light detector comprising a plurality of light detector fibres position to detect light transmitted through or reflected from the body part.
- a preferred embodiment of the invention is one wherein the non-pulsatile element of the patient's blood is utilised.
- a device for the non-invasive measurement of one or more analytes in blood in a patient's body part as herein before described which is adapted to measure the non-pulsatile element of a patient's blood.
- the device measures the pulsatile and non-pulsatile elements of a patient's blood.
- the device may be so adapted by being provided with a plurality of closely associated transmitters and generators which allows an "average" evened out signal to be produced.
- the detector of the invention is especially useful in measuring blood glucose level.
- a device for the non-invasive measurement of one or more analytes in blood in a patient's body part as herein before described which is adapted to measure blood glucose levels.
- the device may be capable of measuring other parameters either separately or in addition to blood glucose.
- An especially advantageous feature is the device may be adapted to measure blood oxygen saturation (SO 2 ).
- SO 2 blood oxygen saturation
- the device may be adapted for use, with any body part although it is preferable that it can be a finger or thumb.
- the number of transmitter fibres may vary although we have found that 18 transmitter fibres works well.
- the number of detector fibres may be the same or different to the number of transmitter fibres, but may vary and we have found that 12 detector fibres works well.
- the diameter of the detector and the transmitter fibres may be the same or different and may vary, a diameter of 250 ⁇ m is preferred.
- the detector fibres are preferably positioned to detect reflected light rather than transmitted light.
- the wavelength used in the transmitter fibres will generally be from 500 to 1 lOOnm.
- a detector as hereinbefore described which also measures haemoglobin index (Hbl) and/or oxygen saturation (SO 2 ) of blood.
- Hbl haemoglobin index
- SO 2 oxygen saturation
- specific wavelengths are used, namely 500.9nm, 528.1nm, 549.5nm, 561. lnm, 572.7nm and 586.3nm.
- the preferred wavelengths for measuring blood glucose are from 800nm to 1 lOOnm.
- a method of measuring blood glucose levels which comprises placing a non-invasive measuring device as hereinbefore described against a body part of a patient and using the detector to measure the light transmitted through or reflected from the body part.
- a device programmed so as to calculate one or more of the haemoglobin index, the oxygen index and the blood oxygen saturation.
- the computer is programmed so as to calculate these equations first if blood oxygen saturation is to be calculated.
- a computer programme product comprising a computer readable medium having thereon computer programme code means, when said programme is loaded, to make the computer execute a procedure to calculate one or more of the haemoglobin index, the oxygen index and the "whole blood” oxygen saturation as herein before described.
- Figure 1 is a plot of the predicted glucose values against the measured glucose values
- Figure la is a graph comparing normal blood glucose levels with those of a diabetic.
- GTTs glucose tolerance tests
- the range displayed during the glucose experiments was 500-1 lOOnm. In order to mimic the broad bandwidth characteristics of the previous glucose monitor above lOOOnm, all measurements were averaged over the range 1000-1 lOOnm. Quartz lightguides were used in conjunction with a 400W quartz-halogen light source.
- a lightguide bundle which consisted of 18 transmitting and 12 receiving fibres each of 250 ⁇ m diameter, was attached to the fingertip of the subject by means of a laser Doppler probe holder. Recordings of spectra were made at 10 min intervals throughout the test using the MCPD spectrophotometer described above. These recordings were accompanied by parallel measurements of glucose concentrations in blood, obtained by pinprick of a contralateral finger with the aid of a Softelix pro lancet system, using a Boehringer Manheim Advantage® glucose monitor. The lightguide was removed from the finger after each measurement and new dark and reference spectra recorded before each new measurement. A total of 13 measurements were carried out over a 2 hour period.
- Hbl and SO 2 were derived from the absorption spectra measured from 500.8 to 586.3nm using a computer program VOXYG written for the purpose.
- the program carried out the following calculations.
- a data file A was created containing the full absorption spectral data (800-1 lOOnm in 1.96nm steps) from all 12 GTTs in the series.
- the absorption values in the file are defined in "absorption units” referred to here as ABUs.
- the other data contained in the file were time, experiment identification, glucose concentration (invasive), Hbl, SO 2 , temperature, and laser Doppler flux.
- D - ABU data of C was further normalised by division by the SO 2 value (ie ABU c /SO 2 ) to take into account the influence of changes in the relative concentrations of oxygenated haemoglobin (HbO 2 ) and deoxygenated haemoglobin (Hb) on the infrared spectrum.
- E - SBU data of D was yet further normalised by subtraction of the value at the assumed water peak (ie ABU D - ABU 949 ) in an attempt to take into account changes in water content.
- the predicted values from the last correlation using data file E are plotted against the measured glucose values in Figure 1.
- the predicted values are given as standardised to the mean and number of standard deviations on the left hand side of the y-axis and as mM on the right hand side.
- Figure 1 could indicate that the method may eventually allow a universal calibration, or at least one based on a particular individual, particularly if the ways in which the spectra are normalised are varied.
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69942391T DE69942391D1 (en) | 1998-07-04 | 1999-07-02 | BLOODY MEASUREMENT OF ANALYTES FROM BLOOD |
US09/743,206 US6990365B1 (en) | 1998-07-04 | 1999-07-02 | Apparatus for measurement of blood analytes |
EP99929558A EP1094745B1 (en) | 1998-07-04 | 1999-07-02 | Non-invasive measurement of blood analytes |
AT99929558T ATE468068T1 (en) | 1998-07-04 | 1999-07-02 | BLOODLESS MEASUREMENT OF ANALYTES FROM BLOOD |
AU46347/99A AU4634799A (en) | 1998-07-04 | 1999-07-02 | Non-invasive measurement of blood analytes |
US10/950,257 US7400918B2 (en) | 1998-07-04 | 2004-09-24 | Measurement of blood oxygen saturation |
US11/049,035 US7424317B2 (en) | 1998-07-04 | 2005-01-25 | Non-invasive measurement of blood analytes |
US12/206,662 US7774037B2 (en) | 1998-07-04 | 2008-09-08 | Non-invasive measurement of blood analytes |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9814464.5A GB9814464D0 (en) | 1998-07-04 | 1998-07-04 | Monitor |
GB9814464.5 | 1998-07-04 | ||
GBGB9824899.0A GB9824899D0 (en) | 1998-11-13 | 1998-11-13 | Monitor |
GB9824899.0 | 1998-11-13 | ||
GBGB9825243.0A GB9825243D0 (en) | 1998-11-19 | 1998-11-19 | Monitor |
GB9825243.0 | 1998-11-19 |
Related Parent Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/002510 Continuation-In-Part WO2000009004A2 (en) | 1998-07-04 | 1999-07-30 | Optical device |
US09/762,923 Continuation-In-Part US6842635B1 (en) | 1998-07-04 | 1999-07-30 | Optical device |
US09762923 Continuation-In-Part | 1999-07-30 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09743206 A-371-Of-International | 1999-07-02 | ||
US10/950,257 Continuation-In-Part US7400918B2 (en) | 1998-07-04 | 2004-09-24 | Measurement of blood oxygen saturation |
US11/049,035 Continuation US7424317B2 (en) | 1998-07-04 | 2005-01-25 | Non-invasive measurement of blood analytes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000001294A1 true WO2000001294A1 (en) | 2000-01-13 |
Family
ID=27269382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/002127 WO2000001294A1 (en) | 1998-07-04 | 1999-07-02 | Non-invasive measurement of blood analytes |
Country Status (6)
Country | Link |
---|---|
US (4) | US6990365B1 (en) |
EP (1) | EP1094745B1 (en) |
AT (1) | ATE468068T1 (en) |
AU (1) | AU4634799A (en) |
DE (1) | DE69942391D1 (en) |
WO (1) | WO2000001294A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001093755A1 (en) * | 2000-06-09 | 2001-12-13 | Whitland Research Limited | Monitor for non-invasive measurement of blood analytes |
US6842635B1 (en) | 1998-08-13 | 2005-01-11 | Edwards Lifesciences Llc | Optical device |
WO2006097437A1 (en) | 2005-03-14 | 2006-09-21 | Spectrum Medical Llp | Monitoring of predetermined substances in blood |
US7809418B2 (en) | 2007-10-04 | 2010-10-05 | The Curators Of The University Of Missouri | Optical device components |
US7961304B2 (en) | 2007-09-13 | 2011-06-14 | The Curators Of The University Of Missouri | Optical device components |
US7961305B2 (en) | 2007-10-23 | 2011-06-14 | The Curators Of The University Of Missouri | Optical device components |
US8340738B2 (en) | 2008-05-22 | 2012-12-25 | The Curators Of The University Of Missouri | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US8506979B2 (en) | 2002-08-28 | 2013-08-13 | Nomir Medical Technologies, Inc. | Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
US8552359B2 (en) | 2009-04-01 | 2013-10-08 | The Curators of the Univesity of Missouri | Optical spectroscopy device for non-invasive blood glucose detection and associated method of use |
US9442065B2 (en) | 2014-09-29 | 2016-09-13 | Zyomed Corp. | Systems and methods for synthesis of zyotons for use in collision computing for noninvasive blood glucose and other measurements |
US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
US10542919B2 (en) | 2008-03-25 | 2020-01-28 | St. Louis Medical Devices, Inc. | Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose |
Families Citing this family (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) * | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US6990365B1 (en) * | 1998-07-04 | 2006-01-24 | Edwards Lifesciences | Apparatus for measurement of blood analytes |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8135448B2 (en) * | 2001-03-16 | 2012-03-13 | Nellcor Puritan Bennett Llc | Systems and methods to assess one or more body fluid metrics |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7033371B2 (en) | 2001-06-12 | 2006-04-25 | Pelikan Technologies, Inc. | Electric lancet actuator |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
AU2002312521A1 (en) * | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
WO2002100461A2 (en) * | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7563232B2 (en) * | 2002-04-19 | 2009-07-21 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7901362B2 (en) * | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7141058B2 (en) * | 2002-04-19 | 2006-11-28 | Pelikan Technologies, Inc. | Method and apparatus for a body fluid sampling device using illumination |
US7232451B2 (en) * | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) * | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7297122B2 (en) * | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7485128B2 (en) * | 2002-04-19 | 2009-02-03 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7674232B2 (en) * | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) * | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) * | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7410468B2 (en) * | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7481776B2 (en) * | 2002-04-19 | 2009-01-27 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
AU2003300154A1 (en) * | 2002-12-31 | 2004-07-29 | Pelikan Technologies Inc. | Method and apparatus for loading penetrating members |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
EP1635702A4 (en) * | 2003-06-11 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) * | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US7534212B2 (en) | 2004-03-08 | 2009-05-19 | Nellcor Puritan Bennett Llc | Pulse oximeter with alternate heart-rate determination |
EP1729644A2 (en) * | 2004-03-19 | 2006-12-13 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | A method for evaluating relative oxygen saturation in body tissues |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US20090312620A1 (en) * | 2005-04-27 | 2009-12-17 | Hou-Mei Henry Chang | Diabetes monitor |
US7319894B2 (en) * | 2005-09-13 | 2008-01-15 | Edwards Lifesciences Corporation | Continuous spectroscopic measurement of total hemoglobin |
US7725146B2 (en) | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for pre-processing waveforms |
US7904130B2 (en) * | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US20100145158A1 (en) * | 2005-10-06 | 2010-06-10 | Hamilton Scott E | Pod Connected Data Monitoring System |
EP2520331A3 (en) | 2006-04-12 | 2013-02-20 | Proteus Digital Health, Inc. | Void-free implantable hermetically sealed structures |
US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US8346327B2 (en) * | 2007-03-09 | 2013-01-01 | Covidien Lp | Method for identification of sensor site by local skin spectrum data |
US8175665B2 (en) * | 2007-03-09 | 2012-05-08 | Nellcor Puritan Bennett Llc | Method and apparatus for spectroscopic tissue analyte measurement |
US20080221416A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | System and method for detection of macular degeneration using spectrophotometry |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US8690864B2 (en) * | 2007-03-09 | 2014-04-08 | Covidien Lp | System and method for controlling tissue treatment |
US20080220512A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | Tunable laser-based spectroscopy system for non-invasively measuring body water content |
US20090292212A1 (en) * | 2008-05-20 | 2009-11-26 | Searete Llc, A Limited Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20090287094A1 (en) * | 2008-05-15 | 2009-11-19 | Seacrete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20090287101A1 (en) * | 2008-05-13 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US9717896B2 (en) | 2007-12-18 | 2017-08-01 | Gearbox, Llc | Treatment indications informed by a priori implant information |
US20090287191A1 (en) * | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20090287109A1 (en) * | 2008-05-14 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US8636670B2 (en) | 2008-05-13 | 2014-01-28 | The Invention Science Fund I, Llc | Circulatory monitoring systems and methods |
US20090287120A1 (en) * | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US8577434B2 (en) * | 2007-12-27 | 2013-11-05 | Covidien Lp | Coaxial LED light sources |
US8140272B2 (en) * | 2008-03-27 | 2012-03-20 | Nellcor Puritan Bennett Llc | System and method for unmixing spectroscopic observations with nonnegative matrix factorization |
US8437822B2 (en) * | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US9314335B2 (en) | 2008-09-19 | 2016-04-19 | Edwards Lifesciences Corporation | Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation |
US20100081912A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | Ultrasound-Optical Doppler Hemometer and Technique for Using the Same |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9517023B2 (en) | 2009-06-01 | 2016-12-13 | Profusa, Inc. | Method and system for directing a localized biological response to an implant |
US8521244B2 (en) * | 2009-09-16 | 2013-08-27 | Analogic Corporation | Physiological parameter monitoring apparatus |
JP2013510678A (en) * | 2009-11-12 | 2013-03-28 | ネルコー ピューリタン ベネット エルエルシー | Hybrid physiological sensor system and method |
US20120029830A1 (en) * | 2009-12-31 | 2012-02-02 | Turner Richard W | Blood glucose measurement devices and methods of using the same |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
WO2011137115A1 (en) * | 2010-04-29 | 2011-11-03 | Eye02 Scan Llc | Determination of oxygen saturation in a tissue of visual system |
US10010272B2 (en) | 2010-05-27 | 2018-07-03 | Profusa, Inc. | Tissue-integrating electronic apparatus |
US8649838B2 (en) | 2010-09-22 | 2014-02-11 | Covidien Lp | Wavelength switching for pulse oximetry |
CN103260501B (en) | 2010-10-06 | 2015-09-02 | 普罗弗萨股份有限公司 | Tissue integration sensor |
US8818473B2 (en) | 2010-11-30 | 2014-08-26 | Covidien Lp | Organic light emitting diodes and photodetectors |
CA2904031A1 (en) | 2013-03-14 | 2014-10-02 | Profusa, Inc. | Method and device for correcting optical signals |
BR112015029988A2 (en) | 2013-06-06 | 2017-07-25 | Profusa Inc | apparatus and methods for detecting optical signals from implanted sensors |
US10213550B2 (en) | 2014-01-23 | 2019-02-26 | Covidien Lp | Systems and methods for monitoring clinical procedures using regional blood oxygen saturation |
US9867561B2 (en) | 2014-01-27 | 2018-01-16 | Covidien Lp | Systems and methods for determining whether regional oximetry sensors are properly positioned |
US9861317B2 (en) | 2014-02-20 | 2018-01-09 | Covidien Lp | Methods and systems for determining regional blood oxygen saturation |
US10328202B2 (en) | 2015-02-04 | 2019-06-25 | Covidien Lp | Methods and systems for determining fluid administration |
KR102339446B1 (en) * | 2016-05-11 | 2021-12-14 | 노바 바이오메디컬 코포레이션 | Whole blood so2 sensor |
WO2018119400A1 (en) | 2016-12-22 | 2018-06-28 | Profusa, Inc. | System and single-channel luminescent sensor for and method of determining analyte value |
US10799312B2 (en) | 2017-04-28 | 2020-10-13 | Edwards Lifesciences Corporation | Medical device stabilizing apparatus and method of use |
CN107255657B (en) * | 2017-06-07 | 2020-01-10 | 苏州大学 | Chaos coding and decoding method for blood sugar nondestructive test |
WO2019181267A1 (en) * | 2018-03-20 | 2019-09-26 | Dynamic Brain Lab合同会社 | Biological information measurement device |
KR20200067592A (en) | 2018-12-04 | 2020-06-12 | 삼성전자주식회사 | Method for guiding measurement of bio signal in wearable device |
IT202000006712A1 (en) * | 2020-03-31 | 2021-10-01 | Medica S P A | SYSTEM FOR MEASURING INTRINSIC PARAMETERS OF AN ORGANIC FLUID CIRCULATING IN A DUCT |
JP7449165B2 (en) * | 2020-05-20 | 2024-03-13 | 日本光電工業株式会社 | Pulse photometer, pulse photometry system, and computer program |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5553613A (en) | 1994-08-17 | 1996-09-10 | Pfizer Inc. | Non invasive blood analyte sensor |
WO1997027800A1 (en) * | 1996-02-05 | 1997-08-07 | Diasense, Inc. | Methods and apparatus for non-invasive glucose sensing: non-invasive probe |
US5755226A (en) * | 1994-01-31 | 1998-05-26 | Minnesota Mining And Manufacturing Company | Method and apparatus for noninvasive prediction of hematocrit |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US662031A (en) * | 1900-03-16 | 1900-11-20 | Louis H Shoemaker | Locomotive turn-table. |
US3638640A (en) * | 1967-11-01 | 1972-02-01 | Robert F Shaw | Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths |
DE2815074C2 (en) | 1978-04-07 | 1983-03-03 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Spectrophotometers for medical purposes |
US4407290A (en) * | 1981-04-01 | 1983-10-04 | Biox Technology, Inc. | Blood constituent measuring device and method |
DE3328862A1 (en) | 1982-09-16 | 1985-02-28 | Siemens AG, 1000 Berlin und 8000 München | Tissue photometry method and device, in particular for quantatively determining the blood oxygen saturation from photometric measurements |
US4623248A (en) * | 1983-02-16 | 1986-11-18 | Abbott Laboratories | Apparatus and method for determining oxygen saturation levels with increased accuracy |
US4752115A (en) * | 1985-02-07 | 1988-06-21 | Spectramed, Inc. | Optical sensor for monitoring the partial pressure of oxygen |
JPS6365845A (en) * | 1986-09-05 | 1988-03-24 | ミノルタ株式会社 | Oximeter apparatus |
US4776340A (en) * | 1987-03-23 | 1988-10-11 | Spectramed, Inc. | Hematocrit measurement by differential optical geometry in a short-term diagnostic cardiovascular catheter, and application to correction of blood-oxygen measurement |
JPS63252239A (en) | 1987-04-09 | 1988-10-19 | Sumitomo Electric Ind Ltd | Reflection type oxymeter |
JPH06103257B2 (en) | 1988-12-19 | 1994-12-14 | 大塚電子株式会社 | Method and apparatus for measuring absorption coefficient of substance using light scattering |
US5061632A (en) * | 1989-01-31 | 1991-10-29 | Board Of Regents, The University Of Texas System | Capillary tube hemoglobinometer and oximeter |
US5040539A (en) * | 1989-05-12 | 1991-08-20 | The United States Of America | Pulse oximeter for diagnosis of dental pulp pathology |
JPH05504266A (en) | 1989-07-27 | 1993-07-08 | ブリティッシュ・テクノロジー・グループ リミテッド | oximeter |
CA2025330C (en) * | 1989-09-18 | 2002-01-22 | David W. Osten | Characterizing biological matter in a dynamic condition using near infrared spectroscopy |
JP3213307B2 (en) * | 1989-09-18 | 2001-10-02 | ミネソタ マイニング アンド マニユフアクチユアリング カンパニー | A method for predicting the properties of biological materials by near-infrared spectral analysis |
US5393371A (en) * | 1989-12-18 | 1995-02-28 | Litton Systems, Inc. | Integrated optics chips and laser ablation methods for attachment of optical fibers thereto for LiNbO3 substrates |
US6681128B2 (en) * | 1990-10-06 | 2004-01-20 | Hema Metrics, Inc. | System for noninvasive hematocrit monitoring |
US5372136A (en) | 1990-10-06 | 1994-12-13 | Noninvasive Medical Technology Corporation | System and method for noninvasive hematocrit monitoring |
US6266546B1 (en) * | 1990-10-06 | 2001-07-24 | In-Line Diagnostics Corporation | System for noninvasive hematocrit monitoring |
EP0574509B1 (en) * | 1991-03-07 | 1999-09-15 | Masimo Corporation | Signal processing apparatus and method |
US5490505A (en) * | 1991-03-07 | 1996-02-13 | Masimo Corporation | Signal processing apparatus |
MX9702434A (en) * | 1991-03-07 | 1998-05-31 | Masimo Corp | Signal processing apparatus. |
WO1992021283A1 (en) | 1991-06-06 | 1992-12-10 | Somanetics Corporation | Optical cerebral oximeter |
US5413100A (en) * | 1991-07-17 | 1995-05-09 | Effets Biologiques Exercice | Non-invasive method for the in vivo determination of the oxygen saturation rate of arterial blood, and device for carrying out the method |
ATE136242T1 (en) * | 1991-12-04 | 1996-04-15 | Bystronic Laser Ag | LASER PROCESSING SYSTEM |
US5277181A (en) * | 1991-12-12 | 1994-01-11 | Vivascan Corporation | Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis |
JP2898489B2 (en) | 1991-12-17 | 1999-06-02 | アー・フアウ・エル・メデイカル・インストルメンツ・アクチエンゲゼルシヤフト | Equipment for spectrophotometric analysis |
WO1993013706A2 (en) * | 1992-01-17 | 1993-07-22 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Optical method for monitoring arterial blood hematocrit |
US5280786A (en) * | 1992-01-21 | 1994-01-25 | Fiberoptic Sensor Technologies, Inc. | Fiberoptic blood pressure and oxygenation sensor |
US5355880A (en) | 1992-07-06 | 1994-10-18 | Sandia Corporation | Reliable noninvasive measurement of blood gases |
US5672875A (en) | 1992-07-15 | 1997-09-30 | Optix Lp | Methods of minimizing scattering and improving tissue sampling in non-invasive testing and imaging |
GB9216431D0 (en) | 1992-08-01 | 1992-09-16 | Univ Swansea | Optical monitoring or measuring artefact suppression |
DK88893D0 (en) * | 1993-07-30 | 1993-07-30 | Radiometer As | A METHOD AND APPARATUS FOR DETERMINING THE CONTENT OF A CONSTITUENT OF BLOOD OF AN INDIVIDUAL |
US5435309A (en) * | 1993-08-10 | 1995-07-25 | Thomas; Edward V. | Systematic wavelength selection for improved multivariate spectral analysis |
JP3464697B2 (en) * | 1993-12-21 | 2003-11-10 | 興和株式会社 | Oxygen saturation meter |
US5672675A (en) * | 1994-07-13 | 1997-09-30 | Alliedsignal, Inc. | Vinyl ether-terminated polyester oligomer stabilizers for vinyl ether-based coating systems |
DE19512478C2 (en) * | 1994-08-10 | 2001-05-31 | Bernreuter Peter | Method for determining arterial oxygen saturation |
US5673692A (en) * | 1995-02-03 | 1997-10-07 | Biosignals Ltd. Co. | Single site, multi-variable patient monitor |
DE19612425C2 (en) * | 1995-03-31 | 2000-08-31 | Nihon Kohden Corp | Apparatus for measuring hemoglobin concentration |
DE19651690C2 (en) * | 1995-12-13 | 2001-12-13 | Bernreuter Peter | Measuring method for determining blood oxygen saturation |
US6226540B1 (en) * | 1995-12-13 | 2001-05-01 | Peter Bernreuter | Measuring process for blood gas analysis sensors |
US6045502A (en) * | 1996-01-17 | 2000-04-04 | Spectrx, Inc. | Analyzing system with disposable calibration device |
FI962448A (en) * | 1996-06-12 | 1997-12-13 | Instrumentarium Oy | Method, apparatus and sensor for the determination of fractional oxygen saturation |
US5879294A (en) * | 1996-06-28 | 1999-03-09 | Hutchinson Technology Inc. | Tissue chromophore measurement system |
WO1998001071A1 (en) * | 1996-07-08 | 1998-01-15 | Animas Corporation | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
AT404513B (en) * | 1996-07-12 | 1998-12-28 | Avl Verbrennungskraft Messtech | METHOD AND MEASURING ARRANGEMENT FOR THE OPTICAL DETERMINATION OF TOTAL HEMOGLOBIN CONCENTRATION |
US6163715A (en) * | 1996-07-17 | 2000-12-19 | Criticare Systems, Inc. | Direct to digital oximeter and method for calculating oxygenation levels |
US5842981A (en) * | 1996-07-17 | 1998-12-01 | Criticare Systems, Inc. | Direct to digital oximeter |
US6544193B2 (en) * | 1996-09-04 | 2003-04-08 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
US5782756A (en) * | 1996-09-19 | 1998-07-21 | Nellcor Puritan Bennett Incorporated | Method and apparatus for in vivo blood constituent analysis |
US5830137A (en) * | 1996-11-18 | 1998-11-03 | University Of South Florida | Green light pulse oximeter |
US5810723A (en) * | 1996-12-05 | 1998-09-22 | Essential Medical Devices | Non-invasive carboxyhemoglobin analyer |
US6397093B1 (en) * | 1996-12-05 | 2002-05-28 | Essential Medical Devices, Inc. | Non-invasive carboxyhemoglobin analyzer |
US5891024A (en) * | 1997-04-09 | 1999-04-06 | Ohmeda Inc. | Two stage calibration and analyte measurement scheme for spectrophotomeric analysis |
DE69700253T2 (en) * | 1997-04-12 | 1999-09-23 | Hewlett Packard Co | Method and device for determining the concentration of an ingredient |
US5983122A (en) * | 1997-12-12 | 1999-11-09 | Ohmeda Inc. | Apparatus and method for improved photoplethysmographic monitoring of multiple hemoglobin species using emitters having optimized center wavelengths |
US6006119A (en) * | 1998-02-04 | 1999-12-21 | Polestar Technologies, Inc. | Non-invasive optical measurement of blood hematocrit |
US6064474A (en) * | 1998-02-06 | 2000-05-16 | Optical Sensors, Inc. | Optical measurement of blood hematocrit incorporating a self-calibration algorithm |
US6078833A (en) * | 1998-03-25 | 2000-06-20 | I.S.S. (Usa) Inc. | Self referencing photosensor |
US6064896A (en) * | 1998-05-06 | 2000-05-16 | Futrex Inc. | Non-invasive measurement of blood glucose using instruments that have less precise detection capability |
US6097975A (en) * | 1998-05-13 | 2000-08-01 | Biosensor, Inc. | Apparatus and method for noninvasive glucose measurement |
US6526298B1 (en) * | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US6662031B1 (en) * | 1998-05-18 | 2003-12-09 | Abbott Laboratoies | Method and device for the noninvasive determination of hemoglobin and hematocrit |
US6990365B1 (en) * | 1998-07-04 | 2006-01-24 | Edwards Lifesciences | Apparatus for measurement of blood analytes |
EP1598003A3 (en) | 1998-08-13 | 2006-03-01 | Whitland Research Limited | Optical device |
US6321100B1 (en) * | 1999-07-13 | 2001-11-20 | Sensidyne, Inc. | Reusable pulse oximeter probe with disposable liner |
US6415233B1 (en) * | 1999-03-04 | 2002-07-02 | Sandia Corporation | Classical least squares multivariate spectral analysis |
US6167297A (en) * | 1999-05-05 | 2000-12-26 | Benaron; David A. | Detecting, localizing, and targeting internal sites in vivo using optical contrast agents |
DE60039796D1 (en) * | 1999-06-16 | 2008-09-18 | Hutchinson Technology | Complete hemoglobin concentration measurement |
US6700661B1 (en) * | 1999-10-14 | 2004-03-02 | Cme Telemetrix, Inc. | Method of optimizing wavelength calibration |
US6751490B2 (en) * | 2000-03-01 | 2004-06-15 | The Board Of Regents Of The University Of Texas System | Continuous optoacoustic monitoring of hemoglobin concentration and hematocrit |
US20030139667A1 (en) * | 2000-04-13 | 2003-07-24 | Hewko Mark D. | Tissue viability/health monitor utilizing near infrared spectroscopy |
US6553241B2 (en) * | 2000-08-31 | 2003-04-22 | Mallinckrodt Inc. | Oximeter sensor with digital memory encoding sensor expiration data |
US7029628B2 (en) * | 2000-12-28 | 2006-04-18 | Stat-Chem Inc. | Portable co-oximeter |
US6501974B2 (en) * | 2001-01-22 | 2002-12-31 | Datex-Ohmeda, Inc. | Compensation of human variability in pulse oximetry |
GB0103030D0 (en) * | 2001-02-07 | 2001-03-21 | Univ London | Spectrum processing and processor |
US6606509B2 (en) * | 2001-03-16 | 2003-08-12 | Nellcor Puritan Bennett Incorporated | Method and apparatus for improving the accuracy of noninvasive hematocrit measurements |
KR100612827B1 (en) * | 2001-04-19 | 2006-08-14 | 삼성전자주식회사 | Method and apparatus for noninvasively measuring hemoglobin concentration and oxygen saturation |
SE0104443D0 (en) * | 2001-12-28 | 2001-12-28 | Hemocue Ab | Analysis method and cuvette for that |
DE60332094D1 (en) * | 2002-02-22 | 2010-05-27 | Masimo Corp | ACTIVE PULSE SPECTROPHOTOMETRY |
KR100455289B1 (en) * | 2002-03-16 | 2004-11-08 | 삼성전자주식회사 | Method of diagnosing using a ray and apparatus thereof |
US6711426B2 (en) * | 2002-04-09 | 2004-03-23 | Spectros Corporation | Spectroscopy illuminator with improved delivery efficiency for high optical density and reduced thermal load |
US6711425B1 (en) * | 2002-05-28 | 2004-03-23 | Ob Scientific, Inc. | Pulse oximeter with calibration stabilization |
US7343185B2 (en) * | 2002-06-21 | 2008-03-11 | Nir Diagnostics Inc. | Measurement of body compounds |
-
1999
- 1999-07-02 US US09/743,206 patent/US6990365B1/en not_active Expired - Lifetime
- 1999-07-02 AT AT99929558T patent/ATE468068T1/en not_active IP Right Cessation
- 1999-07-02 AU AU46347/99A patent/AU4634799A/en not_active Abandoned
- 1999-07-02 WO PCT/GB1999/002127 patent/WO2000001294A1/en active Application Filing
- 1999-07-02 DE DE69942391T patent/DE69942391D1/en not_active Expired - Lifetime
- 1999-07-02 EP EP99929558A patent/EP1094745B1/en not_active Expired - Lifetime
-
2005
- 2005-01-25 US US11/049,035 patent/US7424317B2/en not_active Expired - Lifetime
-
2008
- 2008-01-15 US US12/014,582 patent/US20080132771A1/en not_active Abandoned
- 2008-09-08 US US12/206,662 patent/US7774037B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5755226A (en) * | 1994-01-31 | 1998-05-26 | Minnesota Mining And Manufacturing Company | Method and apparatus for noninvasive prediction of hematocrit |
US5553613A (en) | 1994-08-17 | 1996-09-10 | Pfizer Inc. | Non invasive blood analyte sensor |
WO1997027800A1 (en) * | 1996-02-05 | 1997-08-07 | Diasense, Inc. | Methods and apparatus for non-invasive glucose sensing: non-invasive probe |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6842635B1 (en) | 1998-08-13 | 2005-01-11 | Edwards Lifesciences Llc | Optical device |
WO2001093755A1 (en) * | 2000-06-09 | 2001-12-13 | Whitland Research Limited | Monitor for non-invasive measurement of blood analytes |
US8506979B2 (en) | 2002-08-28 | 2013-08-13 | Nomir Medical Technologies, Inc. | Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
WO2006097437A1 (en) | 2005-03-14 | 2006-09-21 | Spectrum Medical Llp | Monitoring of predetermined substances in blood |
US7961304B2 (en) | 2007-09-13 | 2011-06-14 | The Curators Of The University Of Missouri | Optical device components |
US7809418B2 (en) | 2007-10-04 | 2010-10-05 | The Curators Of The University Of Missouri | Optical device components |
US7961305B2 (en) | 2007-10-23 | 2011-06-14 | The Curators Of The University Of Missouri | Optical device components |
US11147482B2 (en) | 2008-03-25 | 2021-10-19 | St. Louis Medical Devices, Inc. | Method and system for non-invasive blood glucose measurement using signal change of the non-glucose components induced by the presence of glucose |
US10542919B2 (en) | 2008-03-25 | 2020-01-28 | St. Louis Medical Devices, Inc. | Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose |
US11076781B2 (en) | 2008-05-22 | 2021-08-03 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US9814415B2 (en) | 2008-05-22 | 2017-11-14 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US8340738B2 (en) | 2008-05-22 | 2012-12-25 | The Curators Of The University Of Missouri | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US10973442B2 (en) | 2008-05-22 | 2021-04-13 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US10959650B2 (en) | 2008-05-22 | 2021-03-30 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US11553859B2 (en) | 2008-05-22 | 2023-01-17 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US10080515B2 (en) | 2008-05-22 | 2018-09-25 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US10070809B2 (en) | 2008-05-22 | 2018-09-11 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US9566024B2 (en) | 2008-05-22 | 2017-02-14 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US9579049B2 (en) | 2008-05-22 | 2017-02-28 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US9877670B2 (en) | 2008-05-22 | 2018-01-30 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US9629576B2 (en) | 2008-05-22 | 2017-04-25 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US9788764B2 (en) | 2008-05-22 | 2017-10-17 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US8552359B2 (en) | 2009-04-01 | 2013-10-08 | The Curators of the Univesity of Missouri | Optical spectroscopy device for non-invasive blood glucose detection and associated method of use |
US9610018B2 (en) | 2014-09-29 | 2017-04-04 | Zyomed Corp. | Systems and methods for measurement of heart rate and other heart-related characteristics from photoplethysmographic (PPG) signals using collision computing |
US9459202B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed Corp. | Systems and methods for collision computing for detection and noninvasive measurement of blood glucose and other substances and events |
US9459203B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed, Corp. | Systems and methods for generating and using projector curve sets for universal calibration for noninvasive blood glucose and other measurements |
US9459201B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed Corp. | Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing |
US9453794B2 (en) | 2014-09-29 | 2016-09-27 | Zyomed Corp. | Systems and methods for blood glucose and other analyte detection and measurement using collision computing |
US9448165B2 (en) | 2014-09-29 | 2016-09-20 | Zyomed Corp. | Systems and methods for control of illumination or radiation collection for blood glucose and other analyte detection and measurement using collision computing |
US9448164B2 (en) | 2014-09-29 | 2016-09-20 | Zyomed Corp. | Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing |
US9442065B2 (en) | 2014-09-29 | 2016-09-13 | Zyomed Corp. | Systems and methods for synthesis of zyotons for use in collision computing for noninvasive blood glucose and other measurements |
US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
Also Published As
Publication number | Publication date |
---|---|
AU4634799A (en) | 2000-01-24 |
EP1094745B1 (en) | 2010-05-19 |
US7774037B2 (en) | 2010-08-10 |
EP1094745A1 (en) | 2001-05-02 |
ATE468068T1 (en) | 2010-06-15 |
US20050131286A1 (en) | 2005-06-16 |
DE69942391D1 (en) | 2010-07-01 |
US20080132771A1 (en) | 2008-06-05 |
US7424317B2 (en) | 2008-09-09 |
US6990365B1 (en) | 2006-01-24 |
US20090005663A1 (en) | 2009-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1094745B1 (en) | Non-invasive measurement of blood analytes | |
US5370114A (en) | Non-invasive blood chemistry measurement by stimulated infrared relaxation emission | |
EP2399517B1 (en) | Method for noninvasive measurement of glucose and apparatus for noninvasive measurement of glucose | |
AU707523B2 (en) | Non-invasive blood analyte sensor | |
EP0548418B1 (en) | Non-invasive determination of glucose concentration in body of patient | |
US6424851B1 (en) | Infrared ATR glucose measurement system (II) | |
US20190167206A1 (en) | System and method for a biosensor integrated in a vehicle | |
US20080004513A1 (en) | VCSEL Tissue Spectrometer | |
EP0828533B1 (en) | Method and apparatus for rapid non-invasive determination of blood composition parameters | |
US20070043281A1 (en) | Method and device for non-invasive measurements of blood parameters | |
JP2005013273A (en) | Blood sugar level measuring device | |
US6958039B2 (en) | Method and instruments for non-invasive analyte measurement | |
US6968222B2 (en) | Methods and device for non-invasive analyte measurement | |
MXPA04008714A (en) | Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers. | |
WO1991015991A1 (en) | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography | |
JP2002527136A (en) | Infrared ATR glucose measurement system | |
JP2007175514A (en) | Implantable sensor and system for in vivo measurement and control of body fluid constituent concentration | |
JP2005095317A (en) | Optical measurement apparatus and blood sugar level measurement apparatus using it | |
CA2383725A1 (en) | Method for determination of analytes using nir, adjacent visible spectrum and discrete nir wavelengths | |
KR100580622B1 (en) | Method and apparatus for noninvasive blood constituent measurement | |
CN115399759A (en) | Non-invasive blood analysis | |
US6975892B2 (en) | Methods for non-invasive analyte measurement from the conjunctiva | |
Poddar et al. | Non-invasive glucose monitoring techniques: A review and current trends | |
Ionescu et al. | Measuring and detecting blood glucose by methods non-invasive | |
Dorsaf et al. | Non-invasive glucose monitoring: Application and technologies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999929558 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999929558 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09743206 Country of ref document: US |